Right heart catheterization and risk stratification in advanced heart failure

Current Heart Failure Reports

Volumn 3, Issue 3, 2006, Pages 143-152

  Craig, Michael ^b   Pereira, Naveen L ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CARDIOVASCULAR RISK; CLINICAL ASSESSMENT; CLINICAL FEATURE; CLINICAL TRIAL; HEART CATHETERIZATION; HEART FAILURE; HEART HEMODYNAMICS; HEART STRESS; HEART TRANSPLANTATION; HEART VOLUME; HUMAN; INTERMETHOD COMPARISON; INVASIVE PROCEDURE; LUNG CAPILLARY PRESSURE; MEDICAL EXPERT; META ANALYSIS; NON INVASIVE PROCEDURE; PATHOPHYSIOLOGY; PATIENT MONITORING; PRACTICE GUIDELINE; PROGNOSIS; REVIEW; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SURVIVAL RATE; SYSTEMATIC REVIEW;

ADULT; BLOOD VOLUME; FEMALE; HEART CATHETERIZATION; HEART FAILURE, CONGESTIVE; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; RISK ASSESSMENT;

EID: 33845467317     PISSN: 15469530     EISSN: 15469549     Source Type: Journal    
DOI: 10.1007/s11897-006-0014-x     Document Type: Review

References (46)

1. Pereira NL, Cooper G: Systolic heart failure: practical implementation of standard guidelines. Clin Cornerstone 2000,3:1-12.
2. Androne AS, Hryniewicz K, Hudaihed A, et al.: Relation of unrecognized hypervolemia in chronic heart failure to clinical status, hemodynamics, and patient outcomes. Am J Cardiol 2004, 93:1254-1259.
3. Drazner MH, Rame JE, Stevenson LW, Dries DL: Prognostic importance of elevated jugular venous pressure and a third heart sound in patients with heart failure. N Engl J Med 2001, 345:574-581.
4. O'Neill JO, Bott-Silverman CE, McRae AT, et al.: B-type natriuretic peptide levels are not a surrogate marker for invasive hemodynamics during management of patients with severe heart failure. Am Heart J 2005, 149:363-369.
5. Anand IS, Fisher LD, Chiang YT, et al.: Change in brain natriuretic peptide and norepinephrine over time and mortality and morbidity in the Valsartan Heart Failure Trial (Val-HeFT). Circulation 2003, 107:1278-1283.
6. Sanders GP, Mendes LA, Colucci WS, Givertz MM: Noninvasive methods for detecting elevated left-sided cardiac filling pressure. J Card Fail 2000, 6:157-164.
7. Albert NM, Hail MD, Li J, et al.: Equivalence of the bioimpedance and thermodilution methods in measuring cardiac output in hospitalized patients with advanced, decompensated chronic heart failure. Am J Crit Care 2004, 13:469-479.
8. Packer M, Abraham WT, Mehra MR, et al.: Utility of impedance cardiography for the identification of short-term risk of clinical decompensation in stable patients with chronic heart failure. J Am Coll Cardiol 2006, 47:2245-2252.
9. Bourge RC: The Chronicle Offers Management to Patients With Advanced Signs and Symptoms of Heart Failure (COMPASS-HF) Study. Paper presented at the American College of Cardiology Annual Scientific Session 2005, Orlando, FL; March 6-9, 2005.
10. Yu CM, Wang L, Chau E, et al.: Intrathoracic impedance monitoring in patients with heart failure. Circulation 2005, 112:841-848.
11. Foreman B, Fishel RS, Odryzynski NL, et al.: Intra-thoracic impedance: a surrogate measure of thoracic fluid-Fluid Accumulation Status Trial (FAST). J Card Fail 2004, 10:S86.
12. ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult - summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure). J Am Coll Cardiol 2005, (46):1116-1143.
13. Adams KF, Lindenfeld J, Arnold JMO, et al.: Executive summary: HFSA 2006 comprehensive heart failure practice guideline. J Card Fail 2006, 12:10-38.
14. Nieminen MS, Bohm M, Cowie MR, et al.: Guidelines on the diagnosis and treatment of acute heart failure-full text. The Task Force on Acute Heart Failure of the European Society of Cardiology. Eur Heart J 2005, 26:384-416.
15. Binanay C, Califf RM, Hasselblad V, et al.: Evaluation Study of Congestive Heart Failure and Pulmonary Artery Catheterization Effectiveness: The ESCAPE trial. JAMA 2005, 294:1625-1633. The ESCAPE trial was the first prospective randomized, controlled trial to evaluate the safety and efficacy of the PAC in the treatment of hospitalized patients with advanced HF.
16. Rose E, Gelijns AC, Moskowitz AJ, et al.: Long-term use of a left ventricular assist device for end stage heart failure. N Engl J Med 2001, 345:1435-1443.
17. Richard C, Warszawski J, Anguel N, et al.: Early use of the pulmonary artery catheter and outcomes in patients with shock and acute respiratory distress syndrome. JAMA 2003, 290:2713-2720.
18. Shah MR, Hasselblad V, Stevenson LW, et al.: Impact of the pulmonary artery catheter in crtically ill patients: meta-analysis of randomized clinical trials. JAMA 2005, 294:1664-1670. A comprehensive meta-analysis of major studies investigating the use and safety of the PAC in patients admitted to the intensive care units.
19. Shah MR, Stinnett SS, McNulty SE, et al.: Hemodynamics as surrogate endpoints for survival in advanced heart failure: an analysis from FIRST. Am Heart J 2001, 141:908-914.
20. Gardner RS, Henderson G, McDonagh TA: The prognostic use of right heart catheterization data in patients with advanced heart failure: how relevant are invasive procedures in risk stratification of advanced heart failure in the era of neurohormones? J Heart Lung Transplant 2005, 24:303-309.
21. Griffin BP, Shah PK, Ferguson J, et al.: Incremental prognostic value of exercise hemodynamic variables in chronic congestive heart failure secondary to coronary artery disease or to dilated cardiomyopathy. Am J Cardiol 1991, 67:848-853.
22. Chomsky DB, Lang CC, Rayos GH, et al.: Hemodynamic exercise testing: a valuable tool in the selection of cardiac transplantation candidates. Circulation 1996, 94:3176-3183.
23. Kovick RB, Tillisch JH, Berens SC, et al.: Vasodilator therapy for chronic left ventricular failure. Circulation 1976, 53:322-328.
24. Stevenson LW, Tillisch JH, Hamilton M, et al.: Importance of hemodynamic response to therapy in predicting survival with ejection fraction ≤ 20% secondary to ischemic or nonischemic dilated cardiomyopathy. Am J Cardiol 1990, 66:1348-1354.
25. Stevenson LW: Are hemodynamic goals viable in tailoring heart failure therapy? Hemodynamic goals are relevant. Circulation 2006, 113:1020-1027. This review article discusses the value of hemodynamic monitoring and the importance of tailoring therapy for individual patients.
26. Morley D, Brozena SC: Assessing risk by hemodynamic profile in patients awaiting cardiac transplantation. Am J Cardiol 1994, 73:379-383.
27. DiSalvo TG, Mathier M, Semigran MJ, Dec GW: Preserved right ventricular ejection fraction predicts exercise capacity and survival in advanced heart failure. J Am Coll Cardiol 1995, 25:1143-1153.
28. Komajda M, Jais JP, Reeves F, et al.: Factors predicting mortality in idiopathic dilated cardiomyopathy. Eur Heart J 1990, 11:824-831.
29. Campana C, Gavazzi A, Berzuini C, et al.: Predictors of prognosis in patients awaiting heart transplantation. J Heart Lung Transplant 1993, 12:756-765.
30. Le Jemtel TH, Alt EU: Are hemodynamic goals viable in tailoring heart failure therapy? Hemodynamic goals are outdated. Circulation 2006, 113:1027-1032. The authors discuss the pitfalls of hemodynamic monitoring to guide therapy in the acute management of chronic HF.
31. Saxon LA, Stevenson WG, Middlekauff HR, et al.: Predicting death from progressive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol 1993, 72:62-65.
32. Keogh Am, Baron DW, Hickie JB: Prognostic guides in patients with idiopathic or ischemic dilated cardiomyopathy assessed for cardiac transplantation. Am J Cardiol 1990, 65:903-908.
33. Aaronson KD, Schwartz JS, Cheng TM, et al.: Development and prospective validation of a clinical index to predict survival in ambulatory patients referred for cardiac transplant evaluation. Circulation 1997, 95:2660-2667.
34. Griepp RB, Stinson EB, Dong E, et al.: Determinants of operative risk in human heart transplantation. Am J Surg 1971, 122:192-197.
35. Delgado JF, Gomez-Sanchez MA, Calzada CS, et al.: Impact of mild pulmonary hypertension on mortality and pulmonary artery pressure profile after heart transplantation. J Heart Lung Transplant 2001, 20:942-948.
36. Addonizio J, Gersony WM, Robbins RC, et al.: Elevated pulmonary vascular resistance and cardiac transplantation. Circulation 1976, 76:V52-V55.
37. Kormos RL, Thompson M, Hardesty RL, et al.: Utility of preoperative right heart catheterization data as a predictor of survival after heart transplantation. J Heart Transplant 1986, 5:391.
38. Murali S, Kormos RL, Urersky BF, et al.: Preoperative pulmonary hemodynamics and early mortality after orthotopic cardiac transplantation: The Pittsburgh experience. Am Heart J 1993, 126:896-904.
39. Costard-Jackle A, Fowler MB: Influence of preoperative pulmonary artery pressure on mortality after heart transplantation: Testing of potential reversibility of pulmonary hypertension with nitroprusside is useful in defining a high risk group. J Am Coll Cardiol 1992, 19:48-54.
40. Butler J, Stankewicz MA, Wu J, et al.: Pre-transplant reversible pulmonary hypertension predicts higher risk for mortality after heart transplantation. J Heart Lung Transplant 2005, 24:170-177.
41. Cohn JN, Pfeffer MA, Rouleau J, et al.: Adverse mortality effect of central sympathetic inhibition with sustained-release moxonidine in patients with heart failure (MOXCON). Eur J Heart Fail 2003, 5:659-667.
42. Cohn JN, Golstein SO, Greenberg BH, et al.: A dose dependent increase in mortality with vesnarinone among patients with severe heart failure. The Vesnarinone Trial Investigators. N Engl J Med 1998, 339:1810-1816.
43. Hind D, Calvert N, McWilliams R, et al.: Ultrasonic locating devices for central venous cannulation: meta-analysis. BMJ 2003, 327:361.
44. Sprung CL, Elser B, Schein RM, et al.: Risk of right bundle-branch block and complete heart block during pulmonary artery catheterization. Crit Care Med 1989, 17:1-3.
45. Kearney TJ, Shabot MM: Pulmonary artery rupture associated with the Swan-Ganz catheter. Chest 1995 108:1349-1352.
46. Connors AF, Speroff T, Dawson NV, et al.: The effectiveness of right heart catheterization in the initial care of critically ill patients. JAMA 1996, 276:889-897.